Hormonal therapy is used by some doctors to shrink the cancer before surgery. Available evidence suggests that while hormonal therapy makes it more likely that the surgical margins will be “clear,” no convincing evidence exists to show it reduces tumor recurrence rates. A possible disadvantage of hormonal therapy before surgery is that it may cause scarring around the prostate gland that sometimes makes it more difficult to perform nerve-sparing surgery.